Double digit returns – Introducing the iCORE-indicator - Innovestor

Double digit returns – Introducing the iCORE-indicator

Since inception, we have through our co-investment service led investments in 24 funding rounds, in a total of 17 companies. The first co-investment, in LNGTainer, was done in Sep-2014, and the latest, in Navigine (follow-on), in Jul-2017. In order to track our co-investment performance, we are now introducing the Innovestor Co-Investment Return Indicator, or iCORE-indicator.

With the iCORE-indicator, we basically seek to answer the following question: if an investor would have invested an equal EUR amount, into all our funding rounds, what would the return be? Return is presented as IRR (annualized percentage) and money-back multiple (x investment amount). We have analyzed the results for 2017.

The iCORE-indicator is sensitive to the methodology used for estimating current fair value of investments. Therefore, our approach is cautious. We value all investments at cost, unless there has been a new funding round, secondary market transaction, M&A, IPO or liquidation. In short, we do not take an active view, but rely on market validation.

As of 3Q2017, the iCORE-indicator is IRR 16.8% / money-back 1.4x. The average holding period for the investments is 17 months. Of 17 companies, 11 are valued at cost, and 6 at a premium based on principles outlined above. Summary presented below.

Author: Wilhelm Lindholm, Partner, Chief Investment Officer at Innovestor Group

 

 

 

 

Join the Nordic co-investment community

 

Sign up to our monthly newsletter and be the first to receive information on our coming funding rounds and industry news

straight to your inbox.

By clicking ‘Subscribe’ you accept Innovestors terms, conditions and privacy policy. You may unsubscribe from these communications at any time.

Read Next

Cajo banner

Portfolio Insight: Cajo Technologies – Building for Growth

This is a feature in our monthly ‘Portfolio insight’ blog series, where we will showcase our portfolio companies and provide insights on their...
08.04.2019

Tenboron Ltd takes BNCT cancer treatment to a new era

One of the most important factors affecting the success of an innovation and startup company is timing. Of course, there also needs to be a un...
02.04.2019

Meet the team – Wilhelm Lindholm

This is a feature in our monthly ‘Meet the team’ series, where we hope you get to know us and our team better. Get to know our Chief Investmen...
29.03.2019